WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination
WHO SAGE Seasonal Influenza Vaccination Recommendations during the COVID-19 Pandemic
Solidarity Therapeutics Trial produces conclusive evidence on the effectiveness of repurposed drugs for COVID-19 in record time
A tribute to Dr LEE Jong-wook, Director-General of WHO
Prequalification of one- and two-dose presentations of preservative-free 10-valent pneumococcal conjugate vaccine from GlaxoSmithKline (GSK) (Synflorix™)
Update on two-dose presentation of preservative-free 10-valent pneumococcal conjugate vaccine from GlaxoSmithKline (GSK) (Synflorix™).
Two-dose presentation of preservative-free Human Papilloma Vaccine from GlaxoSmithKline (GSK) (Cervarix™).
Statement from the Global Advisory Committee on Vaccine Safety
